What Are the Possible Side Effects
Hunger is also not a reliable indicator of losing fat
In this biopsychosocial context, GLP-1 RAs are best viewed not as a standalone solution, but as a facilitator of durable, self-directed change
No, Ozempic (semaglutide) will not be detected in standard workplace urine drug tests, as these screenings target substances of abuse and controlled medications, not peptide-based diabetes treatments
NA, Not Applicable (for relevant criterias)
UK patients enquiring about this combination should be aware of its unlicensed status and directed towards evidence-based alternatives available through NHS pathways, including GLP-1 receptor agonists, orlistat, and behavioural interventions recommended by NICE guidance